• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间质干细胞源性外泌体 Lnc A2M-AS1 减轻心肌细胞缺氧/复氧诱导的细胞凋亡和氧化应激。

Mesenchymal Stem Cell-Originated Exosomal Lnc A2M-AS1 Alleviates Hypoxia/Reperfusion-Induced Apoptosis and Oxidative Stress in Cardiomyocytes.

机构信息

Department of Cardiovascular Surgery Intensive Care Unit, The Second Affiliated Hospital of Hainan Medical College, Haikou City, Hainan Province, China.

Department of Critical Care Medicine, The Second Affiliated Hospital of Hainan Medical College, Haikou City, Hainan Province, China.

出版信息

Cardiovasc Drugs Ther. 2023 Oct;37(5):891-904. doi: 10.1007/s10557-022-07339-7. Epub 2022 May 11.

DOI:10.1007/s10557-022-07339-7
PMID:35543792
Abstract

BACKGROUND

Mesenchymal stem cell (MSC)-derived exosomes play significant roles in ameliorating cardiac damage after myocardial ischemia-reperfusion (I/R) injury. Long non-coding RNA alpha-2-macroglobulin antisense RNA 1 (Lnc A2M-AS1) was found that might protect against myocardial I/R. However, whether Lnc A2M-AS1 delivery via MSC-derived exosomes could also regulate myocardial I/R injury remains unknown.

METHODS

Exosomes were isolated by ultracentrifugation, and qualified by transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), and Western blot. Hypoxia/reoxygenation (H/R) treatment in human cardiomyocytes was used to mimic the process of myocardial I/R in vitro. The viability and apoptosis of cardiomyocytes were detected using cell counting kit-8, flow cytometry, and Western blot assays. The contents of lactate dehydrogenase (LDH), malondialdehyde (MDA), and superoxide dismutase (SOD) were evaluated using corresponding commercial kits. The quantitative real-time polymerase chain reaction and Western blot were used to determine the expression levels of Lnc A2M-AS1, microRNA (miR)-556-5p, and X-linked inhibitor of apoptosis protein (XIAP). The binding interaction between miR-556-5p and Lnc A2M-AS1 or XIAP was confirmed by the dual-luciferase reporter, RIP and pull-down assays.

RESULTS

Exosomes isolated from hMSCs (hMSCs-exo) attenuated H/R-induced apoptosis and oxidative stress in cardiomyocytes. Lnc A2M-AS1 was lowly expressed in AMI patients and H/R-induced cardiomyocytes. Besides, Lnc A2M-AS1 was detectable in hMSCs-exo, exosomes derived from Lnc A2M-AS1-transfected hMSCs weakened H/R-induced apoptosis and oxidative stress, and enhanced the protective action of hMSCs-exo on H/R-induced cardiomyocytes. Further mechanism analysis showed that Lnc A2M-AS1 acted as a sponge for miR-556-5p to increase XIAP expression level. Importantly, miR-556-5p overexpression or XIAP knockdown reversed the action of exosomal Lnc A2M-AS1 on H/R-induced cardiomyocytes.

CONCLUSION

Lnc A2M-AS1 delivery via MSC-derived exosomes ameliorated H/R-induced cardiomyocyte apoptosis and oxidative stress via regulating miR-556-5p/XIAP, opening a new window into the pathogenesis of myocardial I/R injury.

摘要

背景

间充质干细胞(MSC)衍生的外泌体在改善心肌缺血再灌注(I/R)损伤后心脏损伤方面发挥重要作用。长链非编码 RNA α-2-巨球蛋白反义 RNA 1(Lnc A2M-AS1)被发现可能对心肌 I/R 具有保护作用。然而,MSC 衍生的外泌体递送 Lnc A2M-AS1 是否也可以调节心肌 I/R 损伤仍然未知。

方法

通过超速离心分离外泌体,并通过透射电子显微镜(TEM)、纳米颗粒跟踪分析(NTA)和 Western blot 进行鉴定。体外使用缺氧/复氧(H/R)处理模拟心肌 I/R 过程。使用细胞计数试剂盒-8、流式细胞术和 Western blot 测定检测心肌细胞的活力和凋亡。使用相应的商业试剂盒评估乳酸脱氢酶(LDH)、丙二醛(MDA)和超氧化物歧化酶(SOD)的含量。使用定量实时聚合酶链反应和 Western blot 测定确定 Lnc A2M-AS1、微小 RNA(miR)-556-5p 和 X 连锁凋亡抑制蛋白(XIAP)的表达水平。通过双荧光素酶报告、RIP 和下拉实验证实 miR-556-5p 与 Lnc A2M-AS1 或 XIAP 之间的结合相互作用。

结果

从 hMSCs(hMSCs-exo)分离的外泌体减轻了 H/R 诱导的心肌细胞凋亡和氧化应激。Lnc A2M-AS1 在 AMI 患者和 H/R 诱导的心肌细胞中表达水平较低。此外,Lnc A2M-AS1 可在 hMSCs-exo 中检测到,转染 Lnc A2M-AS1 的 hMSCs 衍生的外泌体减弱了 H/R 诱导的凋亡和氧化应激,并增强了 hMSCs-exo 对 H/R 诱导的心肌细胞的保护作用。进一步的机制分析表明,Lnc A2M-AS1 作为 miR-556-5p 的海绵以增加 XIAP 表达水平。重要的是,miR-556-5p 的过表达或 XIAP 的敲低逆转了外泌体 Lnc A2M-AS1 对 H/R 诱导的心肌细胞的作用。

结论

通过 MSC 衍生的外泌体递送 Lnc A2M-AS1 通过调节 miR-556-5p/XIAP 改善 H/R 诱导的心肌细胞凋亡和氧化应激,为心肌 I/R 损伤的发病机制开辟了新的窗口。

相似文献

1
Mesenchymal Stem Cell-Originated Exosomal Lnc A2M-AS1 Alleviates Hypoxia/Reperfusion-Induced Apoptosis and Oxidative Stress in Cardiomyocytes.间质干细胞源性外泌体 Lnc A2M-AS1 减轻心肌细胞缺氧/复氧诱导的细胞凋亡和氧化应激。
Cardiovasc Drugs Ther. 2023 Oct;37(5):891-904. doi: 10.1007/s10557-022-07339-7. Epub 2022 May 11.
2
LncRNA KLF3-AS1 in human mesenchymal stem cell-derived exosomes ameliorates pyroptosis of cardiomyocytes and myocardial infarction through miR-138-5p/Sirt1 axis.长链非编码 RNA KLF3-AS1 可改善人骨髓间充质干细胞来源的细胞外囊泡介导的心肌细胞细胞焦亡及心肌梗死,其作用机制可能与 miR-138-5p/Sirt1 轴有关。
Stem Cell Res Ther. 2019 Dec 17;10(1):393. doi: 10.1186/s13287-019-1522-4.
3
LncRNA A2M-AS1 lessens the injury of cardiomyocytes caused by hypoxia and reoxygenation via regulating IL1R2.长链非编码 RNA A2M-AS1 通过调节 IL1R2 减轻心肌细胞缺氧/复氧损伤。
Genes Genomics. 2020 Dec;42(12):1431-1441. doi: 10.1007/s13258-020-01007-6. Epub 2020 Oct 14.
4
Protective effect of bone marrow mesenchymal stem cell-derived exosomes on cardiomyoblast hypoxia-reperfusion injury through the HAND2-AS1/miR-17-5p/Mfn2 axis.骨髓间充质干细胞来源的外泌体通过 HAND2-AS1/miR-17-5p/Mfn2 轴对心肌细胞缺氧再灌注损伤的保护作用。
BMC Cardiovasc Disord. 2023 Mar 7;23(1):114. doi: 10.1186/s12872-023-03148-4.
5
Long Noncoding RNA Taurine-Upregulated Gene 1 Knockdown Protects Cardiomyocytes Against Hypoxia/Reoxygenation-induced Injury Through Regulating miR-532-5p/Sox8 Axis.长链非编码RNA牛磺酸上调基因1敲低通过调控miR-532-5p/Sox8轴保护心肌细胞免受缺氧/复氧诱导的损伤。
J Cardiovasc Pharmacol. 2020 Nov;76(5):556-563. doi: 10.1097/FJC.0000000000000895.
6
MiR-134-5p targeting XIAP modulates oxidative stress and apoptosis in cardiomyocytes under hypoxia/reperfusion-induced injury.靶向X连锁凋亡抑制蛋白的微小RNA-134-5p调节缺氧/复灌注诱导损伤下心肌细胞的氧化应激和细胞凋亡。
IUBMB Life. 2020 Oct;72(10):2154-2166. doi: 10.1002/iub.2351. Epub 2020 Aug 14.
7
MiR-183-5p overexpression in bone mesenchymal stem cell-derived exosomes protects against myocardial ischemia/reperfusion injury by targeting FOXO1.骨间充质干细胞来源的外泌体中 miR-183-5p 的过表达通过靶向 FOXO1 保护心肌缺血/再灌注损伤。
Immunobiology. 2022 May;227(3):152204. doi: 10.1016/j.imbio.2022.152204. Epub 2022 Mar 7.
8
Silencing of SNHG6 alleviates hypoxia/reoxygenation-induced cardiomyocyte apoptosis by modulating miR-135a-5p/HIF1AN to activate Shh/Gli1 signalling pathway.沉默 SNHG6 通过调节 miR-135a-5p/HIF1AN 减轻低氧/复氧诱导的心肌细胞凋亡,从而激活 Shh/Gli1 信号通路。
J Pharm Pharmacol. 2021 Mar 1;73(1):22-31. doi: 10.1093/jpp/rgaa064.
9
Mesenchymal stem cell-originated exosomal lncRNA HAND2-AS1 impairs rheumatoid arthritis fibroblast-like synoviocyte activation through miR-143-3p/TNFAIP3/NF-κB pathway.间质干细胞来源的外泌体 lncRNA HAND2-AS1 通过 miR-143-3p/TNFAIP3/NF-κB 通路损害类风湿关节炎成纤维样滑膜细胞的激活。
J Orthop Surg Res. 2021 Feb 6;16(1):116. doi: 10.1186/s13018-021-02248-1.
10
Upregulation of Long Noncoding RNA FGD5-AS1 Ameliorates Myocardial Ischemia/Reperfusion Injury via MicroRNA-106a-5p and MicroRNA-106b-5p.长链非编码 RNA FGD5-AS1 通过微小 RNA-106a-5p 和微小 RNA-106b-5p 减轻心肌缺血/再灌注损伤。
J Cardiovasc Pharmacol. 2021 Jul 1;78(1):e45-e54. doi: 10.1097/FJC.0000000000001036.

引用本文的文献

1
Exosomes from Stem Cells: A Future Alternative to Whole-Cell Therapy in Heart Failure.干细胞来源的外泌体:心力衰竭中全细胞治疗的未来替代方案
Cardiovasc Drugs Ther. 2025 Sep 12. doi: 10.1007/s10557-025-07777-z.
2
Exosome‑mediated crosstalk between the cardiovascular and musculoskeletal systems: Mechanisms and therapeutic potential (Review).外泌体介导的心血管系统与肌肉骨骼系统之间的串扰:机制与治疗潜力(综述)
Int J Mol Med. 2025 Sep;56(3). doi: 10.3892/ijmm.2025.5570. Epub 2025 Jun 27.
3
MSC-Derived Extracellular Vesicles: Roles and Molecular Mechanisms for Tissue Repair.

本文引用的文献

1
Protective effect of bone marrow mesenchymal stem cell-derived exosomes on cardiomyoblast hypoxia-reperfusion injury through the miR-149/let-7c/Faslg axis.骨髓间充质干细胞衍生的外泌体通过 miR-149/let-7c/Faslg 轴对心肌细胞缺氧再灌注损伤的保护作用。
Free Radic Res. 2020 Oct;54(10):722-731. doi: 10.1080/10715762.2020.1837793. Epub 2020 Nov 6.
2
MiR-134-5p targeting XIAP modulates oxidative stress and apoptosis in cardiomyocytes under hypoxia/reperfusion-induced injury.靶向X连锁凋亡抑制蛋白的微小RNA-134-5p调节缺氧/复灌注诱导损伤下心肌细胞的氧化应激和细胞凋亡。
IUBMB Life. 2020 Oct;72(10):2154-2166. doi: 10.1002/iub.2351. Epub 2020 Aug 14.
3
间充质干细胞衍生的细胞外囊泡:组织修复中的作用和分子机制
Int J Nanomedicine. 2025 Jun 21;20:7953-7974. doi: 10.2147/IJN.S525394. eCollection 2025.
4
Role of Exosomes in Cardiovascular Disease: A Key Regulator of Intercellular Communication in Cardiomyocytes.外泌体在心血管疾病中的作用:心肌细胞间通讯的关键调节因子
ACS Omega. 2025 May 5;10(18):18145-18169. doi: 10.1021/acsomega.4c11423. eCollection 2025 May 13.
5
The role of long non-coding RNA A2M-AS1 in early diagnosis and prognosis evaluation of acute myocardial infarction.长链非编码RNA A2M-AS1在急性心肌梗死早期诊断及预后评估中的作用
J Cardiothorac Surg. 2025 Mar 25;20(1):163. doi: 10.1186/s13019-025-03381-2.
6
Olfactory mucosal mesenchymal stem cell-derived exosome Lnc A2M-AS1 ameliorates oxidative stress by regulating TP53INP1-mediated mitochondrial autophagy through interacting with IGF2BP1 in Parkinson's diseases.嗅黏膜间充质干细胞衍生外泌体Lnc A2M-AS1通过与IGF2BP1相互作用调节TP53INP1介导的线粒体自噬,从而改善帕金森病中的氧化应激。
Cell Biol Toxicol. 2025 Mar 20;41(1):60. doi: 10.1007/s10565-025-10009-7.
7
Role of non-coding RNAs in the pathogenesis of viral myocarditis.非编码RNA在病毒性心肌炎发病机制中的作用。
Virulence. 2025 Dec;16(1):2466480. doi: 10.1080/21505594.2025.2466480. Epub 2025 Feb 20.
8
Innovative Therapeutic Strategies for Myocardial Infarction Across Various Stages: Non-Coding RNA and Stem Cells.心肌梗死各阶段的创新治疗策略:非编码RNA与干细胞
Int J Mol Sci. 2024 Dec 30;26(1):231. doi: 10.3390/ijms26010231.
9
The Potential of Mesenchymal Stem Cell-Derived Exosomes in Cardiac Repair.间充质干细胞衍生外泌体在心脏修复中的潜力
Int J Mol Sci. 2024 Dec 17;25(24):13494. doi: 10.3390/ijms252413494.
10
Mesenchymal Stem Cell-Derived Exosomes: A Promising Therapeutic Strategy for Age-Related Diseases.间充质干细胞衍生外泌体:一种治疗年龄相关性疾病的有前景的治疗策略。
Cell Prolif. 2025 May;58(5):e13795. doi: 10.1111/cpr.13795. Epub 2024 Dec 20.
Exosomal lncRNA AK139128 Derived from Hypoxic Cardiomyocytes Promotes Apoptosis and Inhibits Cell Proliferation in Cardiac Fibroblasts.
低氧心肌细胞来源的外泌体 lncRNA AK139128 促进心肌成纤维细胞凋亡和抑制细胞增殖。
Int J Nanomedicine. 2020 May 12;15:3363-3376. doi: 10.2147/IJN.S240660. eCollection 2020.
4
Exosomal miR-25-3p from mesenchymal stem cells alleviates myocardial infarction by targeting pro-apoptotic proteins and EZH2.间充质干细胞来源的外泌体 miR-25-3p 通过靶向促凋亡蛋白和 EZH2 减轻心肌梗死。
Cell Death Dis. 2020 May 5;11(5):317. doi: 10.1038/s41419-020-2545-6.
5
Circulating exosomes and exosomal lncRNA HIF1A-AS1 in atherosclerosis.循环外泌体及外泌体长链非编码RNA HIF1A-AS1与动脉粥样硬化
Int J Clin Exp Pathol. 2017 Aug 1;10(8):8383-8388. eCollection 2017.
6
HAND2-AS1 inhibits invasion and metastasis of cervical cancer cells via microRNA-330-5p-mediated LDOC1.HAND2-AS1通过微小RNA-330-5p介导的LDOC1抑制宫颈癌细胞的侵袭和转移。
Cancer Cell Int. 2019 Dec 27;19:353. doi: 10.1186/s12935-019-1048-y. eCollection 2019.
7
Mesenchymal stem cells' homing and cardiac tissue repair.间充质干细胞的归巢与心脏组织修复。
Acta Biochim Pol. 2019 Dec 13;66(4):483-489. doi: 10.18388/abp.2019_2890.
8
Inhibition of lncRNA XIST Improves Myocardial I/R Injury by Targeting miR-133a through Inhibition of Autophagy and Regulation of SOCS2.lncRNA XIST的抑制通过靶向miR-133a抑制自噬并调节SOCS2改善心肌缺血/再灌注损伤。
Mol Ther Nucleic Acids. 2019 Dec 6;18:764-773. doi: 10.1016/j.omtn.2019.10.004. Epub 2019 Oct 11.
9
Expression profiling and bioinformatics analysis of circulating microRNAs in patients with acute myocardial infarction.急性心肌梗死患者循环微小 RNA 的表达谱分析和生物信息学分析。
J Clin Lab Anal. 2020 Mar;34(3):e23099. doi: 10.1002/jcla.23099. Epub 2019 Nov 12.
10
Exosomes in ischemic heart disease: novel carriers for bioinformation.缺血性心脏病中的细胞外囊泡:新型生物信息载体。
Biomed Pharmacother. 2019 Dec;120:109451. doi: 10.1016/j.biopha.2019.109451. Epub 2019 Oct 3.